Abstract
A retrospective cohort study examining psychiatric inpatients in New York state has found that use of second‐generation antipsychotics was associated with reduced risk of COVID‐19 infection. Conversely, use of valproic acid was associated with increased risk of COVID‐19. Study results were published online May 6, 2022, in JAMA Network Open.